Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Muhonen

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Melanoma Research|November 1, 1992
Improving the prognostic value of DNA flow cytometry in metastatic melanoma by combining ploidy and S-phase fractionT Muhonen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patientsA G Maiche, T Muhonen
Natural Immunity and Cell Growth Regulation|January 1, 1987
Increased number of functionally defective large granular lymphocytes in lymphoma patientsT Muhonen, L Teerenhovi, E Saksela
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Comment on ESMO Magnitude of Clinical Benefit ScaleT Muhonen, H Joensuu, P Pfeiffer
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: an overview of randomized trialsM Hernberg, S Pyrhönen, T Muhonen
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Second cancer among long-term survivors from Hodgkin's diseaseP Nyandoto, T Muhonen, H Joensuu
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma?M Hernberg, T Muhonen, S Pyrhönen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
A promising interferon plus four-drug chemotherapy regimen for metastatic melanomaS Pyrhönen, M Hahka-Kemppinen, T Muhonen
Lancet (London, England)|October 3, 1992
Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatmentA G Maiche, T Muhonen, K Porkka
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1993
[Treatment of advanced melanoma with a combination of interferon and chemotherapy]S Pyrhönen, M Hahka-Kemppinen, T Muhonen
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Melanoma Research|November 1, 1992
Improving the prognostic value of DNA flow cytometry in metastatic melanoma by combining ploidy and S-phase fractionT Muhonen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patientsA G Maiche, T Muhonen
Natural Immunity and Cell Growth Regulation|January 1, 1987
Increased number of functionally defective large granular lymphocytes in lymphoma patientsT Muhonen, L Teerenhovi, E Saksela
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Comment on ESMO Magnitude of Clinical Benefit ScaleT Muhonen, H Joensuu, P Pfeiffer
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: an overview of randomized trialsM Hernberg, S Pyrhönen, T Muhonen
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Second cancer among long-term survivors from Hodgkin's diseaseP Nyandoto, T Muhonen, H Joensuu
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma?M Hernberg, T Muhonen, S Pyrhönen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
A promising interferon plus four-drug chemotherapy regimen for metastatic melanomaS Pyrhönen, M Hahka-Kemppinen, T Muhonen
Lancet (London, England)|October 3, 1992
Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatmentA G Maiche, T Muhonen, K Porkka
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1993
[Treatment of advanced melanoma with a combination of interferon and chemotherapy]S Pyrhönen, M Hahka-Kemppinen, T Muhonen
Pageof 6